Medications withdrawn over India plant concerns

A number of commonly used medications have been withdrawn from pharmacies over concerns at an Indian manufacturing facility.

All in-date batches of the products have been recalled by the Irish Medicines Board (IMB) following what the board refers to as “a number of significant non-compliances” with best manufacturing practice at the Wockhardt plant in Chikalthana, India.

Three Irish-authorised products and a further 10 unlicensed medicines supplied to Irish pharmacies have been withdrawn. These include medicines commonly used to treat depression, high blood pressure and heart failure.